AAAAAA
Results:
1-22
|
Results: 22
Authors:
Nicholson, RI
Hutcheson, IR
Harper, ME
Knowlden, JM
Barrow, D
McClelland, RA
Jones, HE
Wakeling, AE
Gee, JMW
Citation: Ri. Nicholson et al., Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer, ENDOCR-R CA, 8(3), 2001, pp. 175-182
Authors:
Nicholson, RI
Gee, JMW
Harper, ME
Citation: Ri. Nicholson et al., EGFR and cancer prognosis, EUR J CANC, 37, 2001, pp. S9-S15
Authors:
Kenny, FS
Willsher, PC
Gee, JMW
Nicholson, RI
Pinder, SE
Ellis, IO
Robertson, JFR
Citation: Fs. Kenny et al., Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer, BREAST CANC, 65(2), 2001, pp. 135-144
Authors:
Gee, JMW
Robertson, JFR
Ellis, IO
Nicholson, RI
Citation: Jmw. Gee et al., Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer, INT J CANC, 95(4), 2001, pp. 247-254
Authors:
Kenny, FS
Gee, JMW
Nicholson, RI
Ellis, IO
Morris, TM
Watson, SA
Bryce, RP
Robertson, JFR
Citation: Fs. Kenny et al., Effect of dietary GLA plus /-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts, INT J CANC, 92(3), 2001, pp. 342-347
Authors:
McClelland, RA
Barrow, D
Madden, TA
Dutkowski, CM
Pamment, J
Knowlden, JM
Gee, JMW
Nicholson, RI
Citation: Ra. Mcclelland et al., Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex), ENDOCRINOL, 142(7), 2001, pp. 2776-2788
Authors:
Robertson, JF
Nicholson, RI
Bundred, NJ
Anderson, E
Rayter, Z
Dowsett, M
Fox, JN
Gee, JMW
Webster, A
Wakeling, AE
Morris, C
Dixon, M
Citation: Jf. Robertson et al., Comparison of the short-term biological effects of 7 alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17 beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer, CANCER RES, 61(18), 2001, pp. 6739-6746
Authors:
Madden, TA
Barrow, D
McClelland, RA
Gee, JMW
Nicholson, RI
Citation: Ta. Madden et al., Modulation of oestrogen action by receptor gene inhibition, EUR J CANC, 36, 2000, pp. S34-S35
Authors:
Gee, JMW
Barroso, AF
Ellis, IO
Robertson, JFR
Nicholson, RI
Citation: Jmw. Gee et al., Biological and clinical associations of c-jun activation in human breast cancer, INT J CANC, 89(2), 2000, pp. 177-186
Authors:
Knowlden, JM
Gee, JMW
Robertson, JFR
Ellis, IO
Nicholson, RI
Citation: Jm. Knowlden et al., A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer, INT J CANC, 89(2), 2000, pp. 209-212
Authors:
Yip, SS
Crew, AJ
Gee, JMW
Hui, R
Blamey, RW
Robertson, JFR
Nicholson, RI
Sutherland, RL
Daly, RJ
Citation: Ss. Yip et al., Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression, INT J CANC, 88(3), 2000, pp. 363-368
Authors:
Kenny, FS
Pinder, SE
Ellis, IO
Gee, JMW
Nicholson, RI
Bryce, RP
Robertson, JFR
Citation: Fs. Kenny et al., Gamma linolenic acid with tamoxifen as primary therapy tn breast cancer, INT J CANC, 85(5), 2000, pp. 643-648
Authors:
Nicholson, RI
Gee, JMW
Citation: Ri. Nicholson et Jmw. Gee, Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer, BR J CANC, 82(3), 2000, pp. 501-513
Authors:
Nicholson, RI
McClelland, RA
Robertson, JFR
Gee, JMW
Citation: Ri. Nicholson et al., Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer, ENDOCR-R CA, 6(3), 1999, pp. 373-387
Authors:
Kenny, FS
Hui, R
Musgrove, EA
Gee, JMW
Blamey, RW
Nicholson, RI
Sutherland, RL
Robertson, JFR
Citation: Fs. Kenny et al., Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer, CLIN CANC R, 5(8), 1999, pp. 2069-2076
Authors:
Davies, EL
Gee, JMW
Cochrane, RA
Jiang, WG
Sharma, AK
Nicholson, RI
Mansel, RE
Citation: El. Davies et al., The immunohistochemical expression of desmoplakin and its role in vivo in the progression and metastasis of breast cancer, EUR J CANC, 35(6), 1999, pp. 902-907
Authors:
Gee, JMW
Robertson, JFR
Ellis, IO
Nicholson, RI
Hurst, HC
Citation: Jmw. Gee et al., Immunohistochemical analysis reveals a tumour suppressor-like role for thetranscription factor AP-2 in invasive breast cancer, J PATHOLOGY, 189(4), 1999, pp. 514-520
Authors:
McClelland, RA
Gee, JMW
O'Sullivan, L
Barnes, DM
Robertson, JFR
Ellis, IO
Nicholson, RI
Citation: Ra. Mcclelland et al., p21(WAF1) expression and endocrine response in breast cancer, J PATHOLOGY, 188(2), 1999, pp. 126-132
Authors:
Seery, LT
Knowlden, JM
Gee, JMW
Robertson, JFR
Kenny, FS
Ellis, IO
Nicholson, RI
Citation: Lt. Seery et al., BRCA1 expression levels predict distant metastasis of sporadic breast cancer (vol 84, pg 258, 1999), INT J CANC, 84(5), 1999, pp. 544-544
Authors:
Seery, LT
Knowlden, JM
Gee, JMW
Robertson, JFR
Kenny, FS
Ellis, IO
Nicholson, RI
Citation: Lt. Seery et al., BRCA1 expression levels predict distant metastasis of sporadic breast cancers, INT J CANC, 84(3), 1999, pp. 258-262
Authors:
Gee, JMW
Willsher, PC
Kenny, FS
Robertson, JFR
Pinder, SE
Ellis, IO
Nicholson, RI
Citation: Jmw. Gee et al., Endocrine response and resistance in breast cancer: A role for the transcription factor Fos, INT J CANC, 84(1), 1999, pp. 54-61
c-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer
Authors:
Willsher, PC
Pinder, SE
Gee, JMW
Ellis, IO
Chan, SY
Nicholson, RI
Blamey, RW
Robertson, JFR
Citation: Pc. Willsher et al., c-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancer, ANTICANC R, 18(5B), 1998, pp. 3695-3698
Risultati:
1-22
|